
Oncology NEWS International
- Oncology NEWS International Vol 8 No 11
- Volume 8
- Issue 11
AstraZeneca Offers CHOICES Prostate Education Program
WILMINGTON, Delaware-Astra-Zeneca has launched CHOICES, a comprehensive resource program for men with prostate cancer and their families. The program contains expert advice to help patients make informed treatment choices and real life messages from survivors, the company said in a news release.
WILMINGTON, DelawareAstra-Zeneca has launched CHOICES, a comprehensive resource program for men with prostate cancer and their families. The program contains expert advice to help patients make informed treatment choices and real life messages from survivors, the company said in a news release.
The CHOICES packet consists of two videocassettes and a short educational booklet.
The first video, Understanding Your Choice, reviews the function of the prostate gland, explains how physicians diagnose prostate cancer, and details the four key treatment selections: surgery, radiation therapy, hormonal therapy, and close surveillance.
The second video, CHOICES Weve Made, approaches the treatment alternatives through the experiences of four actual prostate cancer patients. Physicians, patients, and family members explain their roles in living with prostate cancer and how they came to their various treatment decisions.
The CHOICES videos showed me how important my role is in prostate cancer treatment and how that choice can affect my life, Robert Wilbert, a prostate cancer survivor from Detroit, said in the release. Now I have a better understanding of the disease and the various therapies I can choose from. After reviewing the tapes with my family, we felt comfortable discussing what method would be best for me.
CHOICES videos are available to prostate cancer patients through their physicians. Doctors will receive CHOICES materials through their AstraZeneca urology sales representatives.
Articles in this issue
over 26 years ago
Anti-VEGF MoAb Promising in Phase II Renal Cancer Studyover 26 years ago
Government Lawsuit Seeks Billions From Tobacco Industryover 26 years ago
NCI Plans a Large Phase III Trial of Lymphoma Vaccineover 26 years ago
NCCN Database Expanding to Include Cancer Pain Outcomesover 26 years ago
Fewer Blacks Than Whites Receive Surgery for Early Stage Lung Cancerover 26 years ago
NSABP Trial Examines Surgery’s Role in Breast Cancerover 26 years ago
Congressional Spouses Honor Three for Cancer Preventionover 26 years ago
Prophylactic Tamoxifen Debated at ECCOover 26 years ago
Survival Advantage for Simultaneous Goserelin and RTover 26 years ago
NCCR Honors Seven Members of Congress as ‘Champions’Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.




































